PHGDH and breast carcinoma: Pollari et al. [23] concluded their analysis with an assessment of PHGDH, PSAT1, and PSPH expression relative to time to relapse in 368 human clinical breast cancer sample cells as well as relative to overall survival time in 393 breast cancer sample cells.